fbpx Skip to main content

Biocom California Newsletter Article

Neurocrine Biosciences Joins Mental Health Advocacy Community and California State and Local Governments to Raise Awareness of Tardive Dyskinesia

  • 2021-05-27T16:54:00.000+0000
  • Author: Neurocrine Biosciences

May is Mental Health Month and it’s an important time to break down stigmas and increase understanding of mental illness and related conditions, like tardive dyskinesia (TD). TD is an involuntary movement disorder that may develop after a few months of taking certain medications to treat bipolar disorder, depression and schizophrenia. The uncontrollable movements of TD, which can affect the face, torso and/or other body parts, can be disruptive to people's lives due to the symptoms and impact on their physical, emotional and social well-being.

To help raise awareness for the approximately 600,000 Americans living with TD, Neurocrine Biosciences spent a great deal of time educating state legislators and working with the mental health advocacy community across the country to help recognize the first full week of May (2-8) as Tardive Dyskinesia Awareness Week for the fourth year in a row.

During the week of May 2-8, 2021, the California State Senate and Assembly passed resolutions proclaiming May 2-8 as TD Awareness Week. This year, 49 states recognized TD Awareness Week as part of Mental Health Month.

The San Diego County Board of Supervisors approved a similar proclamation (right) sponsored by Supervisor Terra Lawson-Remer in honor of all who live with the condition. Below is a list of activities in California that supported TD Awareness Week:

  • Thursday, April 29: Assembly Member, Kevin Mullin read Assembly Resolution, HR 19 into the record on the California State Assembly Floor designating May 2-8 as TD Awareness Week.
  • Tuesday, May 4: California Senator, Bob Archuleta read Senate Resolution, SR 20 into the record on the California State Senate Floor designating May 2-8 as TD Awareness Week.
  • Wednesday, May 5: The California Movement Disorders Policy Coalition (MPDC) hosted a webinar titled, Why TD Matters: A Virtual Event in Support of Mental Health Awareness Month and Tardive Dyskinesia Awareness Week, which was sponsored by 16 advocacy associations, and discussed the impact of COVID-19 on mental health and associated conditions like TD. Guest speakers included: Senator, Bob Archuleta, Assembly Members, Kevin Mullin and Brian Maienschein, and Dr. Rami Apelian, clinical advocate for the treatment of people with mental health and associated conditions and was moderated by Josie Cooper, Executive Director of MDPC.
  • Friday, May 7: The historic San Diego County Administration Building was lit-up blue in honor of San Diego County’s recognition of TD Awareness Week.


The San Diego County Administration Center was lit up blue to honor Tardive Dyskinesia (TD) Awareness Week during Mental Health Month. The County of San Diego and the California State Senate and Assembly proclaimed May 2-8 as TD Awareness Week to recognize the ~600K Americans living with TD. (Photo by Kent Horner/Getty Images for Neurocrine Biosciences.)

Neurocrine Biosciences is committed to supporting people living with mental health and related disorders like tardive dyskinesia. The first FDA-approved treatment for adults with TD was developed by Neurocrine Biosciences. Neurocrine Biosciences has also invested in programs and resources to help those living with TD and their care partners understand the condition, recognize the symptoms, learn about available support resources, learn about treatment options and initiate a conversation with their healthcare provider on how to best control their involuntary movements. For more resources and information on tardive dyskinesia, visit TalkAboutTD.com and follow @TalkAboutTD on Twitter and Facebook.